Tech Company Financing Transactions
MicroTransponder Funding Round
MicroTransponder closed a $53 million Series E funding round on 6/20/2022. Investors included U.S. Venture Partners, Action Potential Venture Capital and Exceller Hunt.
Transaction Overview
Company Name
Announced On
6/20/2022
Transaction Type
Venture Equity
Amount
$53,000,000
Round
Series E
Investors
U.S. Venture Partners (Lead Investor) (Casey Tansey)
Proceeds Purpose
The company plans to use the funds to commercialize the Vivistim Paired VNS System and establish it as the recommended rehabilitation intervention for stroke survivors working to improve their quality of life through more hand and arm mobility.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2802 Flintrock Trace
Austin, TX 78738
USA
Austin, TX 78738
USA
Phone
Website
Email Address
Overview
MicroTransponder Inc. is a medical device development company with a strong neuroscience research focus. Our core technology is based on a previous technology developed in the DARPA Revolutionizing Prosthetics program by Dr. Larry Cauller at the University of Texas at Dallas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frank McEachern
Chief Operating Officer
Jordan Curnes
Chief Scientific Officer
Navzer Engineer
VP - Regulatory Affairs
Brent Tarver
VP - Sales
JP Allar
Browse more venture capital transactions:
Prev: 6/20/2022: Elypta venture capital transaction
Next: 6/20/2022: INSTANDA venture capital transaction
Share this article
News on VC Transactions
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs